Christopher McNulty
Overview
Christopher McNulty received an average of $666K in total compensation, including $252K in salary, at InVivo Therapeutics Holdings from 2015 to 2018.
Source: SEC filings on November 26, 2019 and April 27, 2018.
Related executives
We found 16 more executives who work or worked at InVivo Therapeutics Holdings.
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
Richard Christopher
InVivo Therapeutics Holdings
Chief Financial Officer
Heather Hamel
InVivo Therapeutics Holdings
Chief Legal Officer
Pamela Stahl
InVivo Therapeutics Holdings
Former Chief Commercial Officer
Mark Perrin
InVivo Therapeutics Holdings
Chief Executive Officer
Thomas Ulich
InVivo Therapeutics Holdings
Chief Scientific Officer
Tamara Joseph
InVivo Therapeutics Holdings
General Counsel
Melanie Morel-Ferris
InVivo Therapeutics Holdings